Skip to the page

Data / Drug companies / KC Pharmaceuticals, Inc.

KC Pharmaceuticals, Inc.: 14 products in the FDA NDC directory, labeler code 55651

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

KC Pharmaceuticals, Inc. (labeler code 55651) lists 14 products in the FDA National Drug Code Directory, covering 10 finished drugs by generic name. By type: 14 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on March 25, 2026.

The request: Watch KC Pharmaceuticals, Inc. (FDA labeler code 55651): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
55651
Products in commercial distribution
14
Packages
14
Finished drugs by generic name
10
Prescription products
0
Over the counter products
14
Flagged as original packager
14 of 14 products that carry the flag
Started marketing in the last 12 months
5
Earliest marketing start
August 28, 2003
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs14100%

Products by type

TypeProductsShare
Over the counter drugs14100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Solution/ drops1071.4%
Solution428.6%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Artificial Tears Lubricant Eye Drops55651-115Solution/ dropsOver the counter monograph drugsMarch 25, 2026
Lubricant Eye Drops55651-105Solution/ dropsOver the counter monograph drugsMarch 15, 2026
Lubricant Eye Drops55651-510Solution/ dropsOver the counter monograph drugsFebruary 25, 2026
Redness and Dry Eye Relief55651-620SolutionOver the counter monograph drugsDecember 26, 2025
Original Redness Reliever55651-063Solution/ dropsOver the counter monograph drugsDecember 26, 2025
Medics Choice Fresh and Soothe55651-200Solution/ dropsOver the counter monograph drugsAugust 1, 2025
Medics Choice Soothing Eye Wash55651-555SolutionOver the counter monograph drugsNovember 30, 2024
Medics Choice Fresh and Soothe Lubricant Eye Drops55651-999Solution/ dropsOver the counter monograph drugsSeptember 1, 2024
Medics Choice Eye Drops Maximum Redness Relief55651-059SolutionOver the counter monograph drugsMarch 27, 2023
Medics Choice Lubricant Eye Drops55651-030SolutionOver the counter monograph drugsFebruary 10, 2020
Medics Choice Eye Drops Advanced55651-025Solution/ dropsOver the counter monograph drugsDecember 9, 2003
Artificial Tears55651-008Solution/ dropsOver the counter monograph drugsNovember 25, 2003
Medics Choice Eye Drops Seasonal Relief55651-024Solution/ dropsOver the counter monograph drugsOctober 23, 2003
Medics Choice Eye Drops Original Redness Reliever55651-005Solution/ dropsOver the counter monograph drugsAugust 28, 2003

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.